ASI Visiting Speaker Program 2025 - Prof Shruti Naik - VIC

Date

Time

12pm-1pm AEST

Venue

In person: Auditorium, Doherty Institute, Melbourne; Zoom: See below

Speakers

Prof Shruti Naik | Associate Professor, Departments of Immunology and Immunotherapy, and Dermatology at the Icahn School of Medicine at Mount Sinai, New York, USA

Price

Description

We are excited to invite you to the next ASI Visiting Speakers Program event.

Dr. Shruti Naik, Ph.D., is an international leader in immunology and tissue stem cell biology. Her research leverages cutting-edge technologies to explore immune cell communication with tissues, with a focus on developing therapies that prevent inflammatory damage and promote organ rejuvenation at cellular and molecular levels.

In-person attendance - Registration not required

There is no need to register to attend this seminar in person.

Zoom attendance - Registration required

This seminar is available via Zoom (live). To attend via Zoom, registrations are required by May 12th 23:59 AEST. Zoom details will be emailed to Zoom registrants on May 13th.

To register for Zoom attendance, please click the green button below. 

If you are attending in-person, there is no need to register via the link below.

COVID SAFE POLICY 

• All delegates and exhibitors may be asked to present a NEGATIVE Rapid Antigen Test before travelling to the conference.
• All attendees must comply with the Safety Plan advised by public health orders to minimise the risk of transmission of COVID-19 on the premises. 
• All attendees are encouraged to wear a mask particularly at indoor venues
• All attendees are encouraged to contact the Organising Committees if they exhibit symptoms and consider cancelling their registration or participating remotely to minimise transmission
• ASI will not cover expenses associated with extra accommodation or alternative transport costs due to isolation requirements should attendees test positive at the event. All attendees should be aware that the events are ‘Attend at your own risk'.